Yvan Jamilloux

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

Sophie Georgin‐Lavialle, Benjamin Terrier, Alexis F. Guédon et al. · British Journal of Dermatology · 2021 · 417 citations · Full text

Medicine, Hematology, Pathology +16

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster et al. · Blood · 2022 · 207 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease

Bruno Fautrel, Stéphane Mitrovic, Arianna De Matteis et al. · Annals of the Rheumatic Diseases · 2024 · 166 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity

Antonia Di Micco, Gianluca Frera, Jérôme Lugrin et al. · Proceedings of the National Academy of Sciences · 2016 · 142 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis

Yvan Jamilloux, Delphine Maucort‐Boulch, Sébastien Kerever et al. · European Respiratory Journal · 2016 · 122 citations · Full text

Public Health, Infectious Diseases, Clinical Epidemiology +16